Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Sandmann S, Unger T
L- and T-type calcium channel blockade - the efficacy of the calcium channel antagonist mibefradil
Journal of Clinical and Basic Cardiology 1999; 2 (2): 187-201

PDF    Summary    Overview   

Fig. 1: Kalziumkanal - Alpha-1-Einheit Fig. 2: L-Typ-Kalziumkanal - Medikamenteninteraktion Fig. 3A-C: Kalziumkanal - Mibefradil This Image - Fig. 4: Kalziumkanal - Mibefradil Fig. 5: Kalziumkanal - Mibefradil Fig. 6: Kalziumkanal - Mibefradil Fig. 7: Kalziumkanal - Mibefradil Last Image
Figure/Graphic 4: Kalziumkanal - Mibefradil
Concentration-response curve for the action of mibefradil on vascular muscle Ca2+ currents shows that the actions are more efficacious on T-type currents (T, black triangle, peak up). L indicates L-type currents (black triangle, peak down). Black square indicates L- and T-type currents. These percent inhibitions are based on reductions of the Ba2+ current (IBa) as shown in figure 3, corresponding T to figure 3A, L to figure 3B, and L and T to figure 3C. Data represent mean +/- SEM for 6 to 16 cells at each concentration.
 
Kalziumkanal - Mibefradil
Previous Image Next Image   


Figure/Graphic 4: Kalziumkanal - Mibefradil
Concentration-response curve for the action of mibefradil on vascular muscle Ca2+ currents shows that the actions are more efficacious on T-type currents (T, black triangle, peak up). L indicates L-type currents (black triangle, peak down). Black square indicates L- and T-type currents. These percent inhibitions are based on reductions of the Ba2+ current (IBa) as shown in figure 3, corresponding T to figure 3A, L to figure 3B, and L and T to figure 3C. Data represent mean +/- SEM for 6 to 16 cells at each concentration.
 
copyright © 2000–2025 Krause & Pachernegg GmbH | Sitemap | Datenschutz | Impressum
 
Werbung